ArticleCNS drugs2017

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Jeffrey H Newcorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.